Track Record of Identifying Rare Wealth CreatorsTrack Record of Identifying Rare Wealth Creators

Blogs

May 31, 2026
Hero Layout Showing a Left Dark blue Panel with the Headline days Payable Outstanding the Working capital Ratio That Reveals Negotiating Power or Hidden Liquidity Stress and a Right Beige Panel Containing a Bar Chart Titled illustrative Dpo Range Across Indian Sectors days with Four Bars It Services 42 Pharma 78 Mid cap Engg 110 Fmcg 120

Days Payable Outstanding: The Working-Capital Ratio That Reveals Negotiating Power or Hidden Liquidity Stress

Days Payable Outstanding (DPO) measures how long a company takes to pay suppliers. Rising DPO can mean franchise-level negotiating power — or hidden liquidity distress. Here is how to tell which, with an FY25 Indian biotech illustration.
May 30, 2026
Borrowings to equity Ratio Sector Benchmarks Editorial Cover

Borrowings-to-Equity Ratio: How One Balance-Sheet Line Separates Capital-Disciplined Compounders From Leverage-Driven Time Bombs

One ratio. Ninety seconds. The single balance-sheet discipline that separates compounders from NCLT cases — explained with the Titan Biotech FY25 audited illustration.
May 29, 2026
Slide Titled Incremental Return on Invested Capital with a Four bar Chart on a Dark Blue Background

Incremental Return on Invested Capital: The Mauboussin-Greenwald Compounder Test That Reveals Whether Every New Rupee of Capital Earns Its Keep

Headline RoIC describes legacy capital; Incremental RoIC describes the most recent rupees deployed. The Mauboussin-Greenwald compounder test, explained step-by-step with audited Indian disclosures.
May 28, 2026
Article Header Sloans Accrual Anomaly Why High accrual Stocks Underperform with Intro Paragraph and Author Byline on a Beige Page

Sloan’s Accrual Anomaly: The 1996 Accounting Review Discovery That High-Accrual Stocks Underperform — And Why the Cash-Backed Earnings Test Is the Single Most Powerful Forensic Filter for Indian Long-Term Investors

Richard Sloan 1996 Accounting Review discovery on high-accrual underperformance and the cash-backed earnings test for Indian long-term investors.
+91-7380122211